1422500-60-4 (Ziresovir,Ziresovir)

结构式:
CAS号:
1422500-60-4
中文名称:
Ziresovir
英文名称:
Ziresovir
分子式:
C22H25N5O3S
分子量:
439.530603170395
简介:
Ziresovir (AK0529; RO-0529) 是一种口服有效的,选择性呼吸道合胞病毒 (RSV) 融合 (F) 蛋白 (RSV F) 抑制剂。 Ziresovir 显示抗 RSV 活性 (EC50=3 nM), 并具有药代动力学表现。

Ziresovir(1422500-60-4)名称与标识符

名称

中文别名:
N-[(3-aminooxetan-3-yl)methyl]-2-(1,1-dioxido-2,3-dihydro-1,4-benzothiazepin-4(5H)-yl)-6-methylquinazolin-4-amine;
英文别名:
N-[(3-aminooxetan-3-yl)methyl]-2-(1,1-dioxido-2,3-dihydro-1,4-benzothiazepin-4(5H)-yl)-6-methylquinazolin-4-amine;Ziresovir;XCF42D7AG4;Ziresovir [INN];N-((3-Aminooxetan-3-yl)methyl)-2-(1,1-dioxido-2,3-dihydro-1,4-benzothiazepin-4(5H)-yl)-6-methylquinazolin-4-amine;GAAICKUTDBZCMT-UHFFFAOYSA-N;DB15145;N-((3-Amino-3-oxetanyl)methyl)-2-(2,3-dihydro-1,1-dioxido-1,4-benzothiazepin-4(5H)-yl)-6-methyl-4-quinazolinamine;4-(4-(((3-Aminooxet;AK0529;RO-0529;BDBM50516304;4-(4-(((3-Aminooxetan-3-yl)methyl)amino)-6-methylquinazolin-2-yl)-2,3,4,5-tetrahydro-1H-1lambd;4-(4-(((3-AMINOOXETAN-3-YL)METHYL)AMINO)-6-METHYLQUINAZOLIN-2-YL)-2,3,4,5-TETRAHYDRO-1H-1.LAMBDA.6,4-BENZOTHIAZEPINE-1,1-DIONE;AK-0529;Ziresovir (RO-0529, AK0529)?;CHEMBL4468815;4-(4-{[(3-aminooxetan-3-yl)methyl]amino}-6-methylquinazolin-2-yl)-2,3,4,5-tetrahydro-1,4-benzothiazepine-1,1-dione;DB-188548;MS-27893;4-Quinazolinamine, N-((3-amino-3-oxetanyl)methyl)-2-(2,3-dihydro-1,1-dioxido-1,4-benzothiazepin-4(5H)-yl)-6-methyl-;ZIRESOVIR [WHO-DD];DTXSID901028129;4-(4-(((3-Aminooxetan-3-yl)methyl)amino)-6-methylquinazolin-2-yl)-2,3,4,5-tetrahydrobenzo[f][1,4]thiazepine 1,1-dioxide;4-(4-(((3-Aminooxetan-3-yl)methyl)amino)-6-methylquinazolin-2-yl)-2,3,4,5-tetrahydro-1H-1lambda6,4-benzothiazepine-1,1-dione;AKOS030527903;SCHEMBL14704847;4-(4-{[(3-aminooxetan-3-yl)methyl]amino}-6-methylquinazolin-2-yl)-2,3,4,5-tetrahydro-1lambda,4-benzothiazepine-1,1-dione;AZ171068;HY-109142;CS-0086934;4-(4-{[(3-aminooxetan-3-yl)methyl]amino}-6-methylquinazolin-2-yl)-2,3,4,5-tetrahydro-1lambda6,4-benzothiazepine-1,1-dione;4-(4-(((3-Aminooxetan-3-yl)methyl)amino)-6-methylquinazolin-2-yl)-2,3,4,5-tetrahydrobenzo[f][1,4]thiazepine1,1-dioxide;UNII-XCF42D7AG4;4-(4-(((3-aminooxetan-3-yl)methyl)amino)-6-methylquinazolin-2-yl)-2,3,4,5-tetrahydro-1lambda6,4-benzothiazepine-1,1-dione;N-((3-aminooxetan-3-yl)methyl)-2-(1,1-dioxo-3,5-dihydro-2H-1lambda6,4-benzothiazepin-4-yl)-6-methylquinazolin-4-amine;ziresovirum;N-[(3-aminooxetan-3-yl)methyl]-2-(1,1-dioxo-3,5-dihydro-2H-1lambda6,4-benzothiazepin-4-yl)-6-methylquinazolin-4-amine;EX-A9744;1422500-60-4;G15903;

标识符

InChIKey:
GAAICKUTDBZCMT-UHFFFAOYSA-N
Inchi:
1S/C22H25N5O3S/c1-15-6-7-18-17(10-15)20(24-12-22(23)13-30-14-22)26-21(25-18)27-8-9-31(28,29)19-5-3-2-4-16(19)11-27/h2-7,10H,8-9,11-14,23H2,1H3,(H,24,25,26)
SMILES:
S1(C2C=CC=CC=2CN(C2=NC3C=CC(C)=CC=3C(=N2)NCC2(COC2)N)CC1)(=O)=O

Ziresovir(1422500-60-4)物化性质

计算特性

  • 精确分子量 : 439.16781085g/mol
  • 氢键供体数量 : 2
  • 氢键受体数量 : 8
  • 可旋转化学键数量 : 4
  • 同位素质量 : 439.16781085g/mol
  • 重原子数量 : 31
  • 复杂度 : 740
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 1.8
  • 拓扑分子极性表面积 : 119

Ziresovir(1422500-60-4)推荐厂家 更多厂家(5)

公司名称手机号/电话联系人QQ微信询单
湖北扬信医药科技有限公司 13092795037
0714-3996388
熊磊 3003473323
询单
上海瀚思化工有限公司 18939883912
021-34536277
顾经理 3003949364
询单
MedChemExpress(MCE 中国) 13611715263
021-58955995
MCE生命科学试剂 2881321772
询单
上海麦克林生化科技股份有限公司 15221275939
021-50706066
沈经理 269348414
询单
上海源溪生物科技有限公司 13564518121李经理 1724405207 询单